A hypoglycaemic 'Peter Pan': a paediatric disease in an adult patient?

Insights

A 56-year-old male with a history of seizures experienced resolution of his condition after treatment for hyperinsulinaemic hypoglycaemia caused by pancreatic nesidioblastosis. This case highlights the importance of blood glucose monitoring in seizure patients.

Area of Science:

  • Endocrinology
  • Neurology
  • Pathology

Background:

  • A 56-year-old male with cerebral palsy and intractable generalized tonic-clonic seizures (GTCS) presented with vomiting.
  • His medical history included lifelong GTCS despite anticonvulsant therapy.

Purpose of the Study:

  • To investigate the cause of seizures in a patient with previously uncontrolled epilepsy.
  • To determine the link between metabolic derangements and neurological symptoms.

Main Methods:

  • Clinical presentation and medical history review.
  • Capillary blood glucose measurement during a seizure.
  • Diagnostic investigations for hyperinsulinaemic hypoglycaemia.
  • Management of nesidioblastosis and monitoring of glycaemic control.

Main Results:

  • A capillary blood glucose of 1.6 mmol/L was recorded during a seizure.
  • Investigations confirmed hyperinsulinaemic hypoglycaemia secondary to diffuse pancreatic nesidioblastosis.
  • Seizure disorder resolved completely with consistent normoglycaemia achieved through nesidioblastosis management.

Conclusions:

  • Unrecognised hyperinsulinaemic hypoglycaemia can manifest as intractable seizures.
  • Diffuse pancreatic nesidioblastosis is a potential cause of hyperinsulinaemic hypoglycaemia in adults.
  • Achieving normoglycaemia is crucial for resolving seizure disorders associated with hyperinsulinaemic hypoglycaemia.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
218
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
111
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
161
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K